LRH-1 expression is elevated in pancreatic cancer and promotes pancreatic cancer cell growth through stimulation of cyclin D1, cyclin E1 and c-Myc (47), while genome-wide association studies implicate mutations in the LRH-1 gene in pancreatic ductal adenocarcinoma (48). The gene discussed is CCND1; the disease is pancreatic neoplasm.